Abstract
During the past years a number of potent and selective antagonists for the human A3 adenosine receptor (AR) have been developed, including tricyclic compounds, such as triazoloquinazoline, pyrazolo-triazolopyridine, imidazopurinone, triazoloquinoxaline and pyrazoloquinoline derivatives. Bicyclic compounds include isoquinoline and related quinazoline derivatives. Monocyclic dihydropyridine and pyridine derivatives also proved to be potent selective A3 AR antagonists. So far, no potent, selective antagonist is available for rodent A3 ARs. Most of the A3 AR antagonists are highly lipophilic and exhibit very poor water-solubility. Potential therapeutic applications for A3 AR antagonists include inflammatory diseases, asthma, stroke, and glaucoma.
Keywords: Adenosine Receptor Antagonists, Imidazo purin-5-ones, Xanthines, Triazoloquinazolines, Pyrazolo-triazolo-pyrimidines, Pyrrolo pyrimidines (7-deazaade-nines), 1,4-Dihydropyridines, Pyridines, Pyrans, Flavonoids
Mini-Reviews in Medicinal Chemistry
Title: A3 Adenosine Receptor Antagonists
Volume: 1 Issue: 4
Author(s): C. E. Muller
Affiliation:
Keywords: Adenosine Receptor Antagonists, Imidazo purin-5-ones, Xanthines, Triazoloquinazolines, Pyrazolo-triazolo-pyrimidines, Pyrrolo pyrimidines (7-deazaade-nines), 1,4-Dihydropyridines, Pyridines, Pyrans, Flavonoids
Abstract: During the past years a number of potent and selective antagonists for the human A3 adenosine receptor (AR) have been developed, including tricyclic compounds, such as triazoloquinazoline, pyrazolo-triazolopyridine, imidazopurinone, triazoloquinoxaline and pyrazoloquinoline derivatives. Bicyclic compounds include isoquinoline and related quinazoline derivatives. Monocyclic dihydropyridine and pyridine derivatives also proved to be potent selective A3 AR antagonists. So far, no potent, selective antagonist is available for rodent A3 ARs. Most of the A3 AR antagonists are highly lipophilic and exhibit very poor water-solubility. Potential therapeutic applications for A3 AR antagonists include inflammatory diseases, asthma, stroke, and glaucoma.
Export Options
About this article
Cite this article as:
Muller E. C., A3 Adenosine Receptor Antagonists, Mini-Reviews in Medicinal Chemistry 2001; 1 (4) . https://dx.doi.org/10.2174/1389557510101040417
DOI https://dx.doi.org/10.2174/1389557510101040417 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
Natural Products in Drug Discovery
Natural products have always been one of the important ways of drug discovery due to their novel skeleton and diverse functional group characteristics. According to statistics, between 1981 and 2019, the FDA approved a total of 1,394 small molecule drugs for marketing, of which 930 marketed drugs originated from the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Characterization, ACE Inhibitory and Antioxidative Properties of Peptide
Fractions Obtained from White Shrimp (<i>Litopenaeus vannamei</i>)
Current Bioactive Compounds Membrane Permeable Lipophilic Cations as Mitochondrial Directing Groups
Current Topics in Medicinal Chemistry In Silico Studies on DARC
Infectious Disorders - Drug Targets Clinical Implications of Macrolide Therapy in Chronic Sinopulmonary Diseases
Current Pharmaceutical Design Refractory Cough as a Remote Manifestation of Retroperitoneal Liposarcoma
Current Cancer Therapy Reviews Multiple Drug Intolerance Syndrome: An Underreported Distinct Clinical Entity
Current Clinical Pharmacology Acute Human Toxicity of Macrocyclic Lactones
Current Pharmaceutical Biotechnology The Protein Kinase Inhibitor Balanol: Structure – Activity Relationships and Structure-Based Computational Studies
Anti-Cancer Agents in Medicinal Chemistry New Ways of Detecting ADRs in Neonates and Children
Current Pharmaceutical Design Fibromyalgia and Bipolar Disorder: Emerging Epidemiological Associations and Shared Pathophysiology
Current Molecular Medicine Active Nano-targeting of Macrophages
Current Pharmaceutical Design An Update on NLRP3 Inflammasome Activation by Engineered Nanomaterials
Current Bionanotechnology (Discontinued) Nutritional Aspects Relating to the Developmental Origins of Health and Disease
Current Women`s Health Reviews Rapid Screening of Different Types of Antitumor Compound Groups from Traditional Chinese Medicine by Hollow Fiber Cell Fishing with High Performance Liquid Chromatography
Combinatorial Chemistry & High Throughput Screening Defining a Role for Mucosal Immunity in the Prevention and Pathogenesis of Respiratory Allergic Diseases
Current Immunology Reviews (Discontinued) Potential of Lung Surfactant Proteins, SP-A and SP-D, and Mannan Binding Lectin for Therapy and Genetic Predisposition to Allergic and Invasive Aspergillosis
Recent Patents on Inflammation & Allergy Drug Discovery Trends in Utilization of the Pharmacological Potential of Chalcones
Current Clinical Pharmacology Use of Transgenic Mouse Models to Understand the Origins of Familial Pulmonary Fibrosis
Current Pharmaceutical Biotechnology Tianeptine: A Novel Atypical Antidepressant that May Provide New Insights into the Biomolecular Basis of Depression
Recent Patents on CNS Drug Discovery (Discontinued) Advancement of Mechanisms of Coxsackie Virus B3-Induced Myocarditis Pathogenesis and the Potential Therapeutic Targets
Current Drug Targets